Insider Transactions in Q1 2025 at Fulgent Genetics, Inc. (FLGT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2025
|
Paul Kim CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
100,000
+22.31%
|
$1,500,000
$15.96 P/Share
|
|
Mar 01
2025
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,481
-0.39%
|
$22,215
$15.45 P/Share
|
|
Mar 01
2025
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.1%
|
$14,775
$15.45 P/Share
|
|
Mar 01
2025
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,556
-0.62%
|
$23,340
$15.45 P/Share
|
|
Feb 26
2025
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,662
-1.83%
|
$74,592
$16.24 P/Share
|
|
Feb 26
2025
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,773
-1.42%
|
$188,368
$16.24 P/Share
|
|
Feb 26
2025
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,523
-0.26%
|
$40,368
$16.24 P/Share
|
|
Feb 25
2025
|
Paul Kim CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
66,878
+6.2%
|
-
|
|
Feb 25
2025
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,166
-2.0%
|
$210,656
$16.29 P/Share
|
|
Feb 25
2025
|
Ming Hsieh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
164,517
+4.79%
|
-
|
|
Feb 25
2025
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,581
-1.57%
|
$569,296
$16.29 P/Share
|
|
Feb 25
2025
|
Jian Xie President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
68,465
+4.26%
|
-
|
|
Feb 25
2025
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,823
-0.52%
|
$29,168
$16.29 P/Share
|
|
Feb 25
2025
|
Hanlin Gao Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,671
+1.47%
|
-
|
|
Feb 25
2025
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,486
-0.27%
|
$119,776
$16.29 P/Share
|
|
Feb 23
2025
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-0.36%
|
$11,728
$16.46 P/Share
|
|
Feb 23
2025
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
417
-0.05%
|
$6,672
$16.46 P/Share
|
|
Feb 23
2025
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,324
-0.33%
|
$37,184
$16.46 P/Share
|
|
Feb 23
2025
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
719
-0.22%
|
$11,504
$16.46 P/Share
|
|
Feb 01
2025
|
Ming Hsieh Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,472
-0.21%
|
$23,552
$16.64 P/Share
|
|
Jan 30
2025
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.01%
|
$1,530
$17.0 P/Share
|
|
Jan 26
2025
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,733
-1.41%
|
$80,461
$17.21 P/Share
|
|
Jan 26
2025
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,329
-0.14%
|
$22,593
$17.21 P/Share
|
|
Jan 26
2025
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,000
-1.47%
|
$51,000
$17.21 P/Share
|